Moderna, Inc.

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-23 pm EST			Pre-market 09:25:26 am
42.39 ^USD	+10.10%		43.28	+2.10%

08:06am	Moderna to Supply COVID-19 Vaccines in EU, Norway	MT
07:25am	Moderna Wins Tender to Supply its COVID-19 Vaccine in the European Union	MT

Health Care Down as RFK Fears Mount -- Health Care Roundup

November 15, 2024 at 05:43 pm EST

Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers.

Shares of Pfizer, AstraZeneca, Novavax and Moderna tumbled. Among European vaccine makers, Bavarian Nordic and Valneva fell by 10% or more.

Getinge shares fell after the Food and Drug Administration said the Swedish maker of hospital equipment was recalling certain blood-work devices.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

11-15-24 1742ET

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
ASTRAZENECA PLC	11,084.00GBX	+0.34%	+1.38%	211B
BAVARIAN NORDIC A/S	202.10DKK	+2.72%	+2.72%	2.15B
GETINGE AB	197.10SEK	-0.90%	+2.36%	4.92B
MODERNA, INC.	42.39USD	+10.10%	+25.56%	16.31B
PFIZER, INC.	26.44USD	+1.65%	-0.19%	150B
NOVAVAX, INC.	9.550USD	+8.15%	+11.96%	1.53B
VALNEVA	2.284EUR	-0.26%	+10.23%	387M

Latest news about Moderna, Inc.

Moderna to Supply COVID-19 Vaccines in EU, Norway	08:06am	MT
Moderna Wins Tender to Supply its COVID-19 Vaccine in the European Union	07:25am	MT
Moderna: Covid vaccine contract with 15 EU countries	06:48am	CF
Moderna, Inc. Receives Tender for Supply of its mRNA COVID-19 Vaccine in European Union	06:30am	CI
Sector Update: Health Care Stocks Higher Late Afternoon	Jan. 21	MT
Top Midday Gainers	Jan. 21	MT
Sector Update: Health Care Stocks Gain in Afternoon Trading	Jan. 21	MT
US Equity Indexes Rise as Treasury Yields Mixed After Trump Administration Avoids Fanning Inflation Expectations	Jan. 21	MT
Sector Update: Health Care	Jan. 21	MT
US Equity Indexes Rise in Midday Trading	Jan. 21	MT
Top Midday Stories: Charles Schwab's Adjusted Earnings Rise; Apple Q4 China Sales Reportedly Drop	Jan. 21	MT
Global markets live: Chevron, Amazon, GSK, Intel, Zalando...	Jan. 20
Moderna Lands $590 Million for Bird Flu Vaccine Development in US	Jan. 19	MT
Moderna Gets $590 Million of Federal Funding For Bird Flu Vaccine -- Update	Jan. 17	DJ
Moderna Gets $590 Million From US Government for Influenza Vaccine Program; Shares Rise After Hours	Jan. 17	MT
US awards Moderna $590 million for bird flu vaccine development	Jan. 17	RE
S&P 500 Logs 2.9% Weekly Gain on Easing Inflationary Pressures, Strong Bank Earnings	Jan. 17	MT
Moderna Gets $590 Million of Federal Funding For Influenza Vaccines	Jan. 17	DJ
Berenberg Bank Adjusts Moderna Price Target to $33 From $42, Maintains Hold Rating	Jan. 16	MT
Banks, bulls and tame inflation	Jan. 16
Analyst recommendations: Datadog, Estee Lauder, Netflix, Moderna, EasyJet...	Jan. 16
Moderna Struggles with COVID-19 Vaccine Market Share, Pipeline Progress, Morgan Stanley Says	Jan. 15	MT
Wall Street rallies on inflation and earnings bonanza	Jan. 15
Morgan Stanley Cuts Price Target on Moderna to $38 From $70, Keeps Equalweight Rating	Jan. 15	MT
Analyst recommendations: Adobe, Intuit, XPO, Netflix, Tesla...	Jan. 15

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (97.4%); - grant revenue (1.4%); - revenue from collaboration agreements (1.2%). At the end of 2023, the group possessed a portfolio of 41 products in clinical development, of which 6 in phase III, 12 in phase II and 18 in phase I, and 5 products in preclinical development. Net sales are distributed geographically as follows: the United States (27.7%), Europe (19.8%) and other (52.5%).

Employees

5,600

Sector

Biotechnology & Medical Research

Calendar

2025-02-13 - Q4 2024 Earnings Call

More about the company